AUPR726201A0 - New use of a cyclic compound - Google Patents

New use of a cyclic compound

Info

Publication number
AUPR726201A0
AUPR726201A0 AUPR7262A AUPR726201A AUPR726201A0 AU PR726201 A0 AUPR726201 A0 AU PR726201A0 AU PR7262 A AUPR7262 A AU PR7262A AU PR726201 A AUPR726201 A AU PR726201A AU PR726201 A0 AUPR726201 A0 AU PR726201A0
Authority
AU
Australia
Prior art keywords
cyclic compound
new use
new
cyclic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR7262A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPR7262A priority Critical patent/AUPR726201A0/en
Publication of AUPR726201A0 publication Critical patent/AUPR726201A0/en
Priority to PCT/JP2002/008443 priority patent/WO2003018019A2/en
Priority to AU2002313591A priority patent/AU2002313591A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
AUPR7262A 2001-08-24 2001-08-24 New use of a cyclic compound Abandoned AUPR726201A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPR7262A AUPR726201A0 (en) 2001-08-24 2001-08-24 New use of a cyclic compound
PCT/JP2002/008443 WO2003018019A2 (en) 2001-08-24 2002-08-21 New use of cyclic compounds
AU2002313591A AU2002313591A1 (en) 2001-08-24 2002-08-21 New use of cyclic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR7262A AUPR726201A0 (en) 2001-08-24 2001-08-24 New use of a cyclic compound

Publications (1)

Publication Number Publication Date
AUPR726201A0 true AUPR726201A0 (en) 2001-09-20

Family

ID=3831215

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR7262A Abandoned AUPR726201A0 (en) 2001-08-24 2001-08-24 New use of a cyclic compound

Country Status (2)

Country Link
AU (1) AUPR726201A0 (en)
WO (1) WO2003018019A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104926707B (en) * 2015-05-12 2017-10-27 江苏福瑞生物医药有限公司 A kind of synthetic method of pharmaceutical intermediate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9611929A (en) * 1995-12-08 1999-05-18 Agouron Pharma Metalloproteinase inhibitors pharmaceutical compositions containing them and their pharmaceutical uses and useful methods and intermediates
NZ334253A (en) * 1996-08-28 2000-11-24 Procter & Gamble N-hydroxy 1-[(4-methoxyphenyl)sulfonyl]-4-benzyloxycarbonyl-piperazine 2-carboxamide and derivatives thereof for treating musculoskeletal disease or cachexia
KR20000057595A (en) * 1996-12-17 2000-09-25 후지야마 아키라 Piperazine compounds as inhibitors of mmp or tnf
BR9807678A (en) * 1997-02-11 2000-02-15 Pfizer Derivatives of arylsulfonyl hydroxamic acids
EP1104412B1 (en) * 1998-08-12 2005-06-15 Pfizer Products Inc. Tace inhibitors
AR035313A1 (en) * 1999-01-27 2004-05-12 Wyeth Corp ACETILENIC TACE INHIBITORS OF HYDROXAMIC ACID OF SULFONAMIDE BASED ON ALFA-AMINO ACIDS, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THE SAME FOR THE MANUFACTURE OF MEDICINES.
EP1081137A1 (en) * 1999-08-12 2001-03-07 Pfizer Products Inc. Selective inhibitors of aggrecanase in osteoarthritis treatment
WO2002067866A2 (en) * 2001-02-27 2002-09-06 Axys Pharmaceuticals, Inc. Piperazine derivatives as metalloprotease inhibitors

Also Published As

Publication number Publication date
WO2003018019A3 (en) 2003-12-04
WO2003018019A2 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
AU2003275828A1 (en) Stator of a moineau-pump
AU2001241142A1 (en) Cyclic compounds
AUPR516901A0 (en) Improvements to a single use syringe
AU2002360487A1 (en) Acyclovir-peptide analogs
AU2002359165A1 (en) Novel compounds
AUPR362001A0 (en) New compound
AU2002328576A1 (en) Cyclic amine compound
AUPR878201A0 (en) New compounds
AU2002351523A1 (en) Monitoring of a reservoir
AUPR409401A0 (en) Analgesic compound
AU2002361117A1 (en) 5-membered cyclic compounds
AUPR755501A0 (en) Cyclic compound
AUPR726201A0 (en) New use of a cyclic compound
AUPR960001A0 (en) A syringe
AU2002313591A1 (en) New use of cyclic compounds
AU2002359317A1 (en) Methods of using 48149, a human aminopeptidase family member
AUPR336301A0 (en) New compound
AUPR336401A0 (en) New compound
AU2002357226A1 (en) The total synthesis of merrilactone a
AUPQ860300A0 (en) Cyclic compound
AUPQ575100A0 (en) Cyclic compound
AU2002250542A1 (en) Novel guanidino compounds
AUPR775701A0 (en) New compounds
AU2002255414A1 (en) New compounds
AU2002316006A1 (en) New compounds